Aqupharm 1 (9 mg/ml) Solution for Injection/Infusion

Country: Bretland

Tungumál: enska

Heimild: VMD (Veterinary Medicines Directorate)

Virkt innihaldsefni:

Sodium Chloride

Fáanlegur frá:

Animalcare Ltd

ATC númer:

QB05BB01

INN (Alþjóðlegt nafn):

Sodium Chloride

Lyfjaform:

Solution for infusion

Gerð lyfseðils:

POM-V - Prescription Only Medicine – Veterinarian

Meðferðarhópur:

Cats, Cattle, Dogs, Goats, Horses, Pigs, Rabbits, Sheep

Lækningarsvæði:

Replacement Agent

Leyfisstaða:

Authorized

Leyfisdagur:

2016-09-22

Vara einkenni

Revised: August 2022
AN: 01024/2022
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Aqupharm 1 (9 mg/ml) solution for injection/infusion
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Sodium Chloride
9 mg
The solution provides
Sodium: 150 mmol/litre
Chloride: 150 mmol/litre
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection/infusion.
Clear, colourless particle free solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle, horses, sheep, goats, pigs, dogs, cats and rabbits.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Correction of water: sodium imbalances.
Treatment of metabolic alkalosis.
Rehydration in disease conditions which result in excessive loss of
water and sodium
chloride, and during and after surgery.
Vehicle solution for the administration of other compatible drugs.
4.3
CONTRAINDICATIONS
Do not use in cases of:
-
sodium and water retention (due to cardiac, hepatic or renal failure,
or
enteropathy)
-
hypernatraemia
-
hyperchloraemia
-
hyperhydration.
Revised: August 2022
AN: 01024/2022
Page 2 of 6
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Maintain aseptic precautions.
Use with caution in animals with cardiac or renal impairment as sodium
overload may
occur.
It
should
be
noted
that
sodium
excretion
may
be
impaired
post-
surgery/trauma.
Use with caution in animals with hypokalaemia.
Serum electrolyte levels, water and acid-base balance and the clinical
condition of
the animal should be closely monitored during the treatment in order
to prevent
overdose, particularly in cases of renal or metabolic changes.
A risk of thrombosis with intravenous infusion should be considered.
This product should not be used for longer than is necessary to
correct and sustain
circulating volume. Inappropriate/excessive use may worsen or create a
metabolic
acidosis.
This product does not contain an antim